Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Phytomenadione API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4689790
    • |
  • 27 April, 2026
    • |
  • Global
    • |
  • 97 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Phytomenadione API market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Phytomenadione API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Phytomenadione API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Phytomenadione API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Phytomenadione API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Phytomenadione API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Phytomenadione API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Phytomenadione API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dsm Nutritional Products Ltd, Biophore India Pharmaceuticals, Hisco Pharmaceuticals, Jiangsu Cixing Pharmaceutical, Anhui Wanhe Pharmaceutical, Sichuan Ren'an Pharmaceutical, Zhejiang Chengyi Pharmaceutical, Shandong Guangtongbao Pharmaceutical, State-owned Zhangjiagang Pharmaceutical Factory, Shanghai Ziyuan Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Phytomenadione API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥99%
Purity<99%
Market segment by Application
Injection
Sterile Powder for Injection
Tablet
Major players covered
Dsm Nutritional Products Ltd
Biophore India Pharmaceuticals
Hisco Pharmaceuticals
Jiangsu Cixing Pharmaceutical
Anhui Wanhe Pharmaceutical
Sichuan Ren'an Pharmaceutical
Zhejiang Chengyi Pharmaceutical
Shandong Guangtongbao Pharmaceutical
State-owned Zhangjiagang Pharmaceutical Factory
Shanghai Ziyuan Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Phytomenadione API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Phytomenadione API, with price, sales quantity, revenue, and global market share of Phytomenadione API from 2021 to 2026.
Chapter 3, the Phytomenadione API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Phytomenadione API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Phytomenadione API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Phytomenadione API.
Chapter 14 and 15, to describe Phytomenadione API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Phytomenadione API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Phytomenadione API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Injection
    • 1.4.3 Sterile Powder for Injection
    • 1.4.4 Tablet
  • 1.5 Global Phytomenadione API Market Size & Forecast
    • 1.5.1 Global Phytomenadione API Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Phytomenadione API Sales Quantity (2021-2032)
    • 1.5.3 Global Phytomenadione API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Dsm Nutritional Products Ltd
    • 2.1.1 Dsm Nutritional Products Ltd Details
    • 2.1.2 Dsm Nutritional Products Ltd Major Business
    • 2.1.3 Dsm Nutritional Products Ltd Phytomenadione API Product and Services
    • 2.1.4 Dsm Nutritional Products Ltd Phytomenadione API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Dsm Nutritional Products Ltd Recent Developments/Updates
  • 2.2 Biophore India Pharmaceuticals
    • 2.2.1 Biophore India Pharmaceuticals Details
    • 2.2.2 Biophore India Pharmaceuticals Major Business
    • 2.2.3 Biophore India Pharmaceuticals Phytomenadione API Product and Services
    • 2.2.4 Biophore India Pharmaceuticals Phytomenadione API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Biophore India Pharmaceuticals Recent Developments/Updates
  • 2.3 Hisco Pharmaceuticals
    • 2.3.1 Hisco Pharmaceuticals Details
    • 2.3.2 Hisco Pharmaceuticals Major Business
    • 2.3.3 Hisco Pharmaceuticals Phytomenadione API Product and Services
    • 2.3.4 Hisco Pharmaceuticals Phytomenadione API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Hisco Pharmaceuticals Recent Developments/Updates
  • 2.4 Jiangsu Cixing Pharmaceutical
    • 2.4.1 Jiangsu Cixing Pharmaceutical Details
    • 2.4.2 Jiangsu Cixing Pharmaceutical Major Business
    • 2.4.3 Jiangsu Cixing Pharmaceutical Phytomenadione API Product and Services
    • 2.4.4 Jiangsu Cixing Pharmaceutical Phytomenadione API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Jiangsu Cixing Pharmaceutical Recent Developments/Updates
  • 2.5 Anhui Wanhe Pharmaceutical
    • 2.5.1 Anhui Wanhe Pharmaceutical Details
    • 2.5.2 Anhui Wanhe Pharmaceutical Major Business
    • 2.5.3 Anhui Wanhe Pharmaceutical Phytomenadione API Product and Services
    • 2.5.4 Anhui Wanhe Pharmaceutical Phytomenadione API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Anhui Wanhe Pharmaceutical Recent Developments/Updates
  • 2.6 Sichuan Ren'an Pharmaceutical
    • 2.6.1 Sichuan Ren'an Pharmaceutical Details
    • 2.6.2 Sichuan Ren'an Pharmaceutical Major Business
    • 2.6.3 Sichuan Ren'an Pharmaceutical Phytomenadione API Product and Services
    • 2.6.4 Sichuan Ren'an Pharmaceutical Phytomenadione API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sichuan Ren'an Pharmaceutical Recent Developments/Updates
  • 2.7 Zhejiang Chengyi Pharmaceutical
    • 2.7.1 Zhejiang Chengyi Pharmaceutical Details
    • 2.7.2 Zhejiang Chengyi Pharmaceutical Major Business
    • 2.7.3 Zhejiang Chengyi Pharmaceutical Phytomenadione API Product and Services
    • 2.7.4 Zhejiang Chengyi Pharmaceutical Phytomenadione API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Zhejiang Chengyi Pharmaceutical Recent Developments/Updates
  • 2.8 Shandong Guangtongbao Pharmaceutical
    • 2.8.1 Shandong Guangtongbao Pharmaceutical Details
    • 2.8.2 Shandong Guangtongbao Pharmaceutical Major Business
    • 2.8.3 Shandong Guangtongbao Pharmaceutical Phytomenadione API Product and Services
    • 2.8.4 Shandong Guangtongbao Pharmaceutical Phytomenadione API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Shandong Guangtongbao Pharmaceutical Recent Developments/Updates
  • 2.9 State-owned Zhangjiagang Pharmaceutical Factory
    • 2.9.1 State-owned Zhangjiagang Pharmaceutical Factory Details
    • 2.9.2 State-owned Zhangjiagang Pharmaceutical Factory Major Business
    • 2.9.3 State-owned Zhangjiagang Pharmaceutical Factory Phytomenadione API Product and Services
    • 2.9.4 State-owned Zhangjiagang Pharmaceutical Factory Phytomenadione API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 State-owned Zhangjiagang Pharmaceutical Factory Recent Developments/Updates
  • 2.10 Shanghai Ziyuan Pharmaceutical
    • 2.10.1 Shanghai Ziyuan Pharmaceutical Details
    • 2.10.2 Shanghai Ziyuan Pharmaceutical Major Business
    • 2.10.3 Shanghai Ziyuan Pharmaceutical Phytomenadione API Product and Services
    • 2.10.4 Shanghai Ziyuan Pharmaceutical Phytomenadione API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Shanghai Ziyuan Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Phytomenadione API by Manufacturer

  • 3.1 Global Phytomenadione API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Phytomenadione API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Phytomenadione API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Phytomenadione API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Phytomenadione API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Phytomenadione API Manufacturer Market Share in 2025
  • 3.5 Phytomenadione API Market: Overall Company Footprint Analysis
    • 3.5.1 Phytomenadione API Market: Region Footprint
    • 3.5.2 Phytomenadione API Market: Company Product Type Footprint
    • 3.5.3 Phytomenadione API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Phytomenadione API Market Size by Region
    • 4.1.1 Global Phytomenadione API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Phytomenadione API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Phytomenadione API Average Price by Region (2021-2032)
  • 4.2 North America Phytomenadione API Consumption Value (2021-2032)
  • 4.3 Europe Phytomenadione API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Phytomenadione API Consumption Value (2021-2032)
  • 4.5 South America Phytomenadione API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Phytomenadione API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Phytomenadione API Sales Quantity by Type (2021-2032)
  • 5.2 Global Phytomenadione API Consumption Value by Type (2021-2032)
  • 5.3 Global Phytomenadione API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Phytomenadione API Sales Quantity by Application (2021-2032)
  • 6.2 Global Phytomenadione API Consumption Value by Application (2021-2032)
  • 6.3 Global Phytomenadione API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Phytomenadione API Sales Quantity by Type (2021-2032)
  • 7.2 North America Phytomenadione API Sales Quantity by Application (2021-2032)
  • 7.3 North America Phytomenadione API Market Size by Country
    • 7.3.1 North America Phytomenadione API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Phytomenadione API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Phytomenadione API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Phytomenadione API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Phytomenadione API Market Size by Country
    • 8.3.1 Europe Phytomenadione API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Phytomenadione API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Phytomenadione API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Phytomenadione API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Phytomenadione API Market Size by Region
    • 9.3.1 Asia-Pacific Phytomenadione API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Phytomenadione API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Phytomenadione API Sales Quantity by Type (2021-2032)
  • 10.2 South America Phytomenadione API Sales Quantity by Application (2021-2032)
  • 10.3 South America Phytomenadione API Market Size by Country
    • 10.3.1 South America Phytomenadione API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Phytomenadione API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Phytomenadione API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Phytomenadione API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Phytomenadione API Market Size by Country
    • 11.3.1 Middle East & Africa Phytomenadione API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Phytomenadione API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Phytomenadione API Market Drivers
  • 12.2 Phytomenadione API Market Restraints
  • 12.3 Phytomenadione API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Phytomenadione API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Phytomenadione API
  • 13.3 Phytomenadione API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Phytomenadione API Typical Distributors
  • 14.3 Phytomenadione API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Phytomenadione API. Industry analysis & Market Report on Phytomenadione API is a syndicated market report, published as Global Phytomenadione API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Phytomenadione API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo